Immunotech Biopharm Ltd. has announced that Dr. Wang Yu has resigned from her roles as executive director, chief executive officer, and chief technology officer, effective June 25, 2025. Mr. Zhang Jian, the senior vice president, has been appointed as the Acting CEO to manage the day-to-day operations of the company. The board has denied any merit to recent allegations made by Dr. Wang and reports no disagreements with other directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.